Immunosuppression effects of bone marrow mesenchymal stem cells on renal interstitial injury in rats with unilateral ureteral obstruction

Cellular Immunology

Volumn 276, Issue 1-2, 2012, Pages 144-152

  Liu, Ying Li ^a   Wang, Ying Deng ^a   Zhuang, Feng ^a   Xian, Shu Li ^a   Fang, Jun Yan ^a   Su, Wei ^a   Zhang, Wei ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Bone marrow mesenchymal stem cells (BMSCs); Immunosuppression; Renal interstitial injury; Unilateral ureteral obstruction (UUO)

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW MESENCHYMAL STEM CELL; CD4+ CD25+ T LYMPHOCYTE; CELL INFILTRATION; CONTROLLED STUDY; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY INJURY; MACROPHAGE; MALE; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGULATORY T LYMPHOCYTE; TH1 CELL; TH2 CELL; UNILATERAL URETER OBSTRUCTION; UPREGULATION; URETER OBSTRUCTION;

ANIMALS; BONE MARROW; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; ECTODYSPLASINS; FORKHEAD TRANSCRIPTION FACTORS; KIDNEY; MALE; MESENCHYMAL STEM CELLS; RATS; RATS, WISTAR; URETERAL OBSTRUCTION;

RATTUS;

EID: 84863867485     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2012.05.001     Document Type: Article

References (36)

1. Semedo P., Palasio C.G., Oliveira C.D., Feitoza C.Q., Goncalves G.M., Cenedeze M.A., Wang P.M., Teixeira V.P., Reis M.A., Pacheco-Silva A., Camara N.O. Early modulation of inflammation by mesenchymal stem cell after acute kidney injury. Int. Immunopharmacol. 2009, 9:677-682.
2. Uccelli A., Pistoia V., Moretta L. Mesenchymal stem cells: a new strategy for immunosuppression?. Trends Immunol. 2007, 28:219-226.
3. Yoo K.H., Jang I.K., Lee M.W., Kim H.E., Yang M.S., Eom Y., Lee J.E., Kim Y.J., Yang S.K., Jung H.L., Sung K.W., Kim C.W., Koo H.H. Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues. Cell Immunol. 2009, 259:150-156.
4. Togel F., Hu Z., Weiss K., Isaac J., Lange C., Westenfelder C. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am. J. Physiol. Renal Physiol. 2005, 289:F31-42.
5. Ikarashi K., Li B., Suwa M., Kawamura K., Morioka T., Yao J., Khan F., Uchiyama M., Oite T. Bone marrow cells contribute to regeneration of damaged glomerular endothelial cells. Kidney Int. 2005, 67:1925-1933.
6. Lin F., Cordes K., Li L., Hood L., Couser W.G., Shankland S.J., Igarashi P. Hematopoietic stem cells contribute to the regeneration of renal tubules after renal ischemia-reperfusion injury in mice. J. Am. Soc. Nephrol. 2003, 14:1188-1199.
7. Togel F., Weiss K., Yang Y., Hu Z., Zhang P., Westenfelder C. Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am. J. Physiol. Renal Physiol. 2007, 292:F1626-1635.
8. Klahr S., Morrissey J. Obstructive nephropathy and renal fibrosis. Am. J. Physiol. Renal Physiol. 2002, 283:F861-875.
9. Gao K., Chen Y., Wei L., Li S., Jin X., Cong C., Yuan Y., Long D., Li Y., Cheng J., Lu Y. Inhibitory effect of mesenchymal stem cells on lymphocyte proliferation. Cell Biochem. Funct. 2008, 26:900-907.
10. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 1995, 155:1151-1164.
11. Hill J.A., Benoist C., Mathis D. Treg cells: guardians for life. Nat. Immunol. 2007, 8:124-125.
12. Nagahama K., Nishimura E., Sakaguchi S. Induction of tolerance by adoptive transfer of Treg cells. Methods Mol. Biol. 2007, 380:431-442.
13. Di Ianni M., Del Papa B., De Ioanni M., Moretti L., Bonifacio E., Cecchini D., Sportoletti P., Falzetti F., Tabilio A. Mesenchymal cells recruit and regulate T regulatory cells. Exp. Hematol. 2008, 36:309-318.
14. Wing K., Sakaguchi S. Regulatory T cells as potential immunotherapy in allergy. Curr. Opin. Allergy Clin. Immunol. 2006, 6:482-488.
15. - T cells through Foxp3 induction and down-regulation of Smad7. J. Immunol. 2004, 172:5149-5153.
16. Stagg J., Pommey S., Eliopoulos N., Galipeau J. Interferon-gamma-stimulated marrow stromal cells: a new type of nonhematopoietic antigen-presenting cell. Blood 2006, 107:2570-2577.
17. Kadiyala S., Young R.G., Thiede M.A., Bruder S.P. Culture expanded canine mesenchymal stem cells possess osteochondrogenic potential in vivo and in vitro. Cell Transplant. 1997, 6:125-134.
18. Marie P.J., Fromigue O. Osteogenic differentiation of human marrow-derived mesenchymal stem cells. Regen. Med. 2006, 1:539-548.
19. Mackay A.M., Beck S.C., Murphy J.M., Barry F.P., Chichester C.O., Pittenger M.F. Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. Tissue Eng. 1998, 4:415-428.
20. Worster A.A., Nixon A.J., Brower-Toland B.D., Williams J. Effect of transforming growth factor beta1 on chondrogenic differentiation of cultured equine mesenchymal stem cells. Am. J. Vet. Res. 2000, 61:1003-1010.
21. Lu H., Guo L., Wozniak M.J., Kawazoe N., Tateishi T., Zhang X., Chen G. Effect of cell density on adipogenic differentiation of mesenchymal stem cells. Biochem. Biophys. Res. Commun. 2009, 381:322-327.
22. Mauney J.R., Volloch V., Kaplan D.L. Matrix-mediated retention of adipogenic differentiation potential by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion. Biomaterials 2005, 26:6167-6175.
23. + proportion in spleen of tumor-bearing BALB/c mice. J. Transl. Med. 2005, 28:5.
24. Wu L.P., Xun L., Yang J., Xu L., Tian Z.F., Gao S., Zhang Y., Hou P., Shi B.Y. Induction of murine neonatal tolerance against Graves' disease using recombinant adenovirus expressing the TSH receptor A-subunit. Endocrinology 2011, 152:1165-1171.
25. Chevalier R.L., Forbes M.S., Thornhill B.A. Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney Int. 2009, 75:1145-1152.
26. + T lymphocytes in acute liver inflammation and injury after ischemia-reperfusion. Am. J. Physiol. Gastrointest. Liver Physiol. 2005, 289:G969-976.
27. Friedewald J.J., Rabb H. Inflammatory cells in ischemic acute renal failure. Kidney Int. 2004, 66:486-491.
28. Wan Y.Y., Flavell R.A. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 2007, 445:766-770.
29. Meisel R., Zibert A., Laryea M., Gobel U., Daubener W., Dilloo D. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 2004, 103:4619-4621.
30. Sabat R., Grutz G., Warszawska K., Kirsch S., Witte E., Wolk K., Geginat J. Biology of interleukin-10. Cytokine Growth Factor Rev. 2010, 21:331-344.
31. Bommireddy R., Doetschman T. TGFβ1 and Treg cells: alliance for tolerance. Trends Mol. Med. 2007, 13:492-501.
32. Tögel F., Cohen A., Zhang P., Yang Y., Hu Z., Westenfelder C. Autologous and allogeneic marrow stromal cells are safe and effective for the treatment of acute kidney injury. Stem Cells Dev. 2009, 18:475-486.
33. Xiao Q., Wang S.K., Tian H., Xin L., Zou Z.G., Hu Y.L., Chang C.M., Wang X.Y., Yin Q.S., Zhang X.H., Wang L.Y. TNF-α increases bone marrow mesenchymal stem cell migration to ischemic tissues. Cell Biochem. Biophys. 2012, 62:409-414.
34. Pantsulaia T. Role of TGF-beta in pathogenesis of diabetic nephropathy. Georgian Med. News 2006, 13-18.
35. Schnaper H.W., Jandeska S., Runyan C.E., Hubchak S.C., Basu R.K., Curley J.F., Smith R.D., Hayashida T. TGF-beta signal transduction in chronic kidney disease. Front Biosci. 2009, 14:2448-2465.
36. Lange C., Togel F., Ittrich H., Clayton F., Nolte-Ernsting C., Zander A.R., Westenfelder C. Administered mesenchymal stem cells enhance recovery from ischemia/reperfusion-induced acute renal failure in rats. Kidney Int. 2005, 68:1613-1617.